Co-Diagnostics (CODX) Announces COVID-19 Test Performance Data 'Demonstrates 100% Sensitivity and 100% Specificity'

Go back to Co-Diagnostics (CODX) Announces COVID-19 Test Performance Data 'Demonstrates 100% Sensitivity and 100% Specificity'

Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations

May 1, 2020 6:30 AM EDT

SALT LAKE CITY, May 1, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today released COVID-19 test performance data demonstrating 100% sensitivity and 100% specificity, the metrics used to define accuracy in molecular diagnostics testing.

... More